Sökning: id:"swepub:oai:DiVA.org:umu-192961" >
Structural Modifica...
Structural Modifications and Biological Evaluations of Rift Valley Fever Virus Inhibitors Identified from Chemical Library Screening
-
- Islam, Koushikul, 1985- (författare)
- Umeå universitet,Institutionen för klinisk mikrobiologi
-
- Carlsson, Marcus (författare)
- Umeå universitet,Kemiska institutionen
-
- Enquist, Per-Anders (författare)
- Umeå universitet,Kemiska institutionen
-
visa fler...
-
- Qian, Weixing (författare)
- Umeå universitet,Kemiska institutionen
-
- Marttila, Marko (författare)
- Umeå universitet,Institutionen för klinisk mikrobiologi
-
- Strand, Mårten, 1982- (författare)
- Umeå universitet,Institutionen för klinisk mikrobiologi
-
- Ahlm, Clas, 1956- (författare)
- Umeå universitet,Institutionen för klinisk mikrobiologi
-
- Evander, Magnus (författare)
- Umeå universitet,Institutionen för klinisk mikrobiologi
-
visa färre...
-
(creator_code:org_t)
- 2022-02-16
- 2022
- Engelska.
-
Ingår i: ACS Omega. - : American Chemical Society (ACS). - 2470-1343. ; 7:8, s. 6854-6868
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://umu.diva-por... (primary) (Raw object)
-
https://pubs.acs.org...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- The Rift Valley fever virus (RVFV) is an emerging high-priority pathogen endemic in Africa with pandemic potential. There is no specific treatment or approved antiviral drugs for the RVFV. We previously developed a cell-based high-throughput assay to screen small molecules targeting the RVFV and identified a potential effective antiviral compound (1-N-(2-(biphenyl-4-yloxy)ethyl)propane-1,3-diamine) as a lead compound. Here, we investigated how structural modifications of the lead compound affected the biological properties and the antiviral effect against the RVFV. We found that the length of the 2-(3-aminopropylamino)ethyl chain of the compound was important for the compound to retain its antiviral activity. The antiviral activity was similar when the 2-(3-aminopropylamino)ethyl chain was replaced with a butyl piperazine chain. However, we could improve the cytotoxicity profile of the lead compound by changing the phenyl piperazine linker from the para-position (compound 9a) to the meta-position (compound 13a). Results from time-of-addition studies suggested that compound 13a might be active during virus post-entry and/or the replication phase of the virus life cycle and seemed to affect the K+ channel. The modifications improved the properties of our lead compound, and our data suggest that 13a is a promising candidate to evaluate further as a therapeutic agent for RVFV infection.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinsk bioteknologi -- Medicinsk bioteknologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Medical Biotechnology -- Medical Biotechnology (hsv//eng)
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Islam, Koushikul ...
-
Carlsson, Marcus
-
Enquist, Per-And ...
-
Qian, Weixing
-
Marttila, Marko
-
Strand, Mårten, ...
-
visa fler...
-
Ahlm, Clas, 1956 ...
-
Evander, Magnus
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Medicinsk biotek ...
-
och Medicinsk biotek ...
- Artiklar i publikationen
-
ACS Omega
- Av lärosätet
-
Umeå universitet